Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumor × YM753 compound × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 8 Docetaxel 8 senaparib 7 Capecitabine 7 Paclitaxel 6 Injections 6 Cisplatin 6 Irinotecan 5 Fluorouracil 5 Leucovorin 4 Cyclophosphamide 4 Bevacizumab 4 tislelizumab 3 pertuzumab 3 fludarabine 3 atezolizumab 3 Rifampin 3 Oxaliplatin 3 Itraconazole 3 Gemcitabine 3 ontuxizumab 2 fluzoparib 2 durvalumab 2 Trastuzumab 2 Nivolumab 2 Midazolam 2 Hydroxychloroquine 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02414516 2019-03-13

A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors

Oncolys BioPharma Inc

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡